FINNPROSTATE Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer
To compare intermittent androgen deprivation (LHRHa treatment) with continuous androgen deprivation (LHRHa treatment or orchidectomy)
Patients With T1-4 Advanced Prostate Cancer
DRUG: Goserelin (Zoladex)
Time To Progression (TTP)
Overall and prostate cancer-specific survival, time to treatment failure, quality of life
To compare intermittent androgen deprivation (LHRHa treatment) with continuous androgen deprivation (LHRHa treatment or orchidectomy)